In many cardiovascular diseases (such as hypertrophy, heart failure, atherosclerosis, endothelial dysfunction), obesity, insulin resistance, diabetes, and chronic kidney diseases are associated with increased GDF‐15 and linked with the progression and prognosis of the disease condition [10]. Here, GDF15 is linked to Insulin resistance.